Skip to content

Clinical trials

Phase 2 Melanoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 2 Country / region: United States Clear all

584 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200113
200212
200317
200428
200529
200626
200727
200823
200921
201025
201130
201219
201328
201423
201523
201615
201717
201818
201922
202022
202127
202215
202313
202412
202511
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed320
Terminated130
Active, not recruiting50
Recruiting37
Unknown status19
Withdrawn19
Not yet recruiting5
Suspended3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)103
M.D. Anderson Cancer Center32
Memorial Sloan Kettering Cancer Center23
Bristol-Myers Squibb18
H. Lee Moffitt Cancer Center and Research Institute9
Alliance for Clinical Trials in Oncology8
Novartis Pharmaceuticals8
University of Southern California8
National Institutes of Health Clinical Center (CC)7
Providence Health & Services7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma584
Skin Neoplasms40
Neoplasm Metastasis39
Uveal Melanoma37
Carcinoma, Non-Small-Cell Lung35
Carcinoma, Renal Cell35
Brain Neoplasms31
Neoplasms29
Breast Neoplasms22
Lung Neoplasms18

Trials

Showing 1 to 25 of 584. Each trial links to its page on Pharma Observatory.

484 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.